Advancements in Nanobody Epitope Prediction: A Comparative Study of AlphaFold2Multimer vs AlphaFold3

Area of Science:

• Biotechnology
• Structural Biology
• Computational Biology

Background:

• Nanobodies are valuable biologics with therapeutic potential.
• Accurate epitope prediction is crucial for nanobody design and optimization.
• Current epitope identification methods like molecular docking require significant expertise.

Purpose of the Study:

• To evaluate the epitope prediction performance of AlphaFold3 and AlphaFold2-Multimer.
• To identify factors influencing nanobody epitope prediction accuracy.
• To assess strategies for improving prediction success rates.

Main Methods:

• Comparative analysis of AlphaFold3 and AlphaFold2-Multimer for nanobody epitope prediction.
• Investigation of CDR3 characteristics (conformation, length) and their impact on binding.
• Evaluation of AlphaFold3's confidence metrics and prediction improvement strategies.

Main Results:

• Overall prediction success rate for both models is below 50%.
• AlphaFold3 shows a modest improvement over AlphaFold2-Multimer.
• Epitope prediction accuracy is strongly correlated with CDR3 spatial conformation and length.

Conclusions:

• Current AI models have limitations in nanobody epitope prediction, necessitating further development.
• CDR3 characteristics are key determinants of binding interactions and prediction accuracy.
• AlphaFold3's confidence metrics show potential for guiding applications, and its approach can inform future model evaluations.